US Stock MarketDetailed Quotes

ENLV Enlivex Therapeutics

Watchlist

1.140
0.0000.00%

Close Nov 29 13:00 ET

1.110
-0.030-2.63%

Post 15:17 ET

25.07MMarket Cap-1163P/E (TTM)

Enlivex Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-44.58%3.12M

-55.09%2.99M

-41.77%3.95M

-2.50%25.15M

-22.36%6.09M

-0.86%5.63M

13.25%6.65M

5.92%6.78M

33.75%25.8M

0.40%7.85M

Selling and administrative expenses

-39.72%771K

-38.85%987K

-31.99%1.09M

-21.92%5.23M

-57.95%733K

-13.35%1.28M

-8.35%1.61M

-6.68%1.61M

7.40%6.7M

-29.75%1.74M

-General and administrative expense

-39.72%771K

-38.85%987K

-31.99%1.09M

-21.92%5.23M

-57.95%733K

-13.35%1.28M

-8.35%1.61M

-6.68%1.61M

7.40%6.7M

-29.75%1.74M

Research and development costs

-46.01%2.35M

-60.30%2M

-44.80%2.86M

1.71%19.01M

-21.89%4.45M

3.52%4.35M

22.51%5.04M

10.55%5.18M

45.12%18.69M

10.34%5.7M

Other operating expenses

----

125.37%906K

----

140.72%402K

----

Operating profit

44.58%-3.12M

55.09%-2.99M

41.77%-3.95M

2.50%-25.15M

22.36%-6.09M

0.86%-5.63M

-13.25%-6.65M

-5.92%-6.78M

-33.75%-25.8M

-0.40%-7.85M

Net non-operating interest income expense

254.33%517K

23.08%-110K

102.53%11K

88.92%1.55M

2.46M

-335K

-143K

-435K

494.71%821K

Non-operating interest income

----

87.43%1.57M

----

595.83%835K

----

Total other finance cost

-254.33%-517K

-23.08%110K

-102.53%-11K

0.00%14K

---899K

--335K

--143K

--435K

-95.73%14K

----

Other net income (expense)

-201K

10.12%-5.47M

-221.00%-6.08M

-105.02%-165K

Gain on sale of security

----

79.88%-1.22M

----

-221.00%-6.08M

----

Special income (charges)

--0

---201K

---4.24M

--0

----

-Gain on sale of property,plant,equipment

--0

---201K

---4.24M

--0

----

Income before tax

56.36%-2.6M

54.42%-3.1M

42.64%-4.14M

6.41%-29.07M

-26.51%-9.1M

-4.01%-5.96M

31.48%-6.79M

12.24%-7.22M

-114.68%-31.06M

-51.79%-7.19M

Income tax

Net income

56.36%-2.6M

54.42%-3.1M

42.64%-4.14M

6.41%-29.07M

-26.51%-9.1M

-4.01%-5.96M

31.48%-6.79M

12.24%-7.22M

-114.68%-31.06M

-51.79%-7.19M

Net income continuous Operations

56.36%-2.6M

54.42%-3.1M

42.64%-4.14M

6.41%-29.07M

-26.51%-9.1M

-4.01%-5.96M

31.48%-6.79M

12.24%-7.22M

-114.68%-31.06M

-51.79%-7.19M

Minority interest income

Net income attributable to the parent company

56.36%-2.6M

54.42%-3.1M

42.64%-4.14M

6.41%-29.07M

-26.51%-9.1M

-4.01%-5.96M

31.48%-6.79M

12.24%-7.22M

-114.68%-31.06M

-51.79%-7.19M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

56.36%-2.6M

54.42%-3.1M

42.64%-4.14M

6.41%-29.07M

-26.51%-9.1M

-4.01%-5.96M

31.48%-6.79M

12.24%-7.22M

-114.68%-31.06M

-51.79%-7.19M

Basic earnings per share

62.50%-0.12

56.76%-0.16

43.59%-0.22

7.69%-1.56

-23.08%-0.48

-3.23%-0.32

31.48%-0.37

13.33%-0.39

-108.64%-1.69

-44.44%-0.39

Diluted earnings per share

62.50%-0.12

56.76%-0.16

43.59%-0.22

7.69%-1.56

-23.08%-0.48

-3.23%-0.32

31.48%-0.37

13.33%-0.39

-108.64%-1.69

-44.44%-0.39

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-44.58%3.12M	-55.09%2.99M	-41.77%3.95M	-2.50%25.15M	-22.36%6.09M	-0.86%5.63M	13.25%6.65M	5.92%6.78M	33.75%25.8M	0.40%7.85M
Selling and administrative expenses	-39.72%771K	-38.85%987K	-31.99%1.09M	-21.92%5.23M	-57.95%733K	-13.35%1.28M	-8.35%1.61M	-6.68%1.61M	7.40%6.7M	-29.75%1.74M
-General and administrative expense	-39.72%771K	-38.85%987K	-31.99%1.09M	-21.92%5.23M	-57.95%733K	-13.35%1.28M	-8.35%1.61M	-6.68%1.61M	7.40%6.7M	-29.75%1.74M
Research and development costs	-46.01%2.35M	-60.30%2M	-44.80%2.86M	1.71%19.01M	-21.89%4.45M	3.52%4.35M	22.51%5.04M	10.55%5.18M	45.12%18.69M	10.34%5.7M
Other operating expenses	----	----	----	125.37%906K	----	----	----	----	140.72%402K	----
Operating profit	44.58%-3.12M	55.09%-2.99M	41.77%-3.95M	2.50%-25.15M	22.36%-6.09M	0.86%-5.63M	-13.25%-6.65M	-5.92%-6.78M	-33.75%-25.8M	-0.40%-7.85M
Net non-operating interest income expense	254.33%517K	23.08%-110K	102.53%11K	88.92%1.55M	2.46M	-335K	-143K	-435K	494.71%821K
Non-operating interest income	----	----	----	87.43%1.57M	----	----	----	----	595.83%835K	----
Total other finance cost	-254.33%-517K	-23.08%110K	-102.53%-11K	0.00%14K	---899K	--335K	--143K	--435K	-95.73%14K	----
Other net income (expense)			-201K	10.12%-5.47M					-221.00%-6.08M	-105.02%-165K
Gain on sale of security	----	----	----	79.88%-1.22M	----	----	----	----	-221.00%-6.08M	----
Special income (charges)	--0	--0	---201K	---4.24M	---4.24M	--0	--0	--0	--0	----
-Gain on sale of property,plant,equipment	--0	--0	---201K	---4.24M	---4.24M	--0	--0	--0	--0	----
Income before tax	56.36%-2.6M	54.42%-3.1M	42.64%-4.14M	6.41%-29.07M	-26.51%-9.1M	-4.01%-5.96M	31.48%-6.79M	12.24%-7.22M	-114.68%-31.06M	-51.79%-7.19M
Income tax
Net income	56.36%-2.6M	54.42%-3.1M	42.64%-4.14M	6.41%-29.07M	-26.51%-9.1M	-4.01%-5.96M	31.48%-6.79M	12.24%-7.22M	-114.68%-31.06M	-51.79%-7.19M
Net income continuous Operations	56.36%-2.6M	54.42%-3.1M	42.64%-4.14M	6.41%-29.07M	-26.51%-9.1M	-4.01%-5.96M	31.48%-6.79M	12.24%-7.22M	-114.68%-31.06M	-51.79%-7.19M
Minority interest income
Net income attributable to the parent company	56.36%-2.6M	54.42%-3.1M	42.64%-4.14M	6.41%-29.07M	-26.51%-9.1M	-4.01%-5.96M	31.48%-6.79M	12.24%-7.22M	-114.68%-31.06M	-51.79%-7.19M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	56.36%-2.6M	54.42%-3.1M	42.64%-4.14M	6.41%-29.07M	-26.51%-9.1M	-4.01%-5.96M	31.48%-6.79M	12.24%-7.22M	-114.68%-31.06M	-51.79%-7.19M
Basic earnings per share	62.50%-0.12	56.76%-0.16	43.59%-0.22	7.69%-1.56	-23.08%-0.48	-3.23%-0.32	31.48%-0.37	13.33%-0.39	-108.64%-1.69	-44.44%-0.39
Diluted earnings per share	62.50%-0.12	56.76%-0.16	43.59%-0.22	7.69%-1.56	-23.08%-0.48	-3.23%-0.32	31.48%-0.37	13.33%-0.39	-108.64%-1.69	-44.44%-0.39
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data